Niacin: When Better Numbers Aren’t Enough
What vitamin B3 can teach us about heart health—and being willing to change our minds
I have always believed that taking care of ourselves means being willing to learn. Sometimes that means adding something helpful. Sometimes it means reconsidering something we have been doing for years.
Niacin is a lovely example of why that willingness matters.
For decades, niacin was used to improve cholesterol levels. It could raise HDL, often called “good” cholesterol, lower triglycerides and LDL, and reduce a blood particle called lipoprotein(a), or Lp(a). On paper, that sounds like quite an accomplishment.
But research eventually asked a more important question: Were those better numbers helping people have fewer heart attacks and strokes—or live longer?
For people already receiving effective statin treatment, the answer was disappointing.
First, niacin is a vitamin we actually need
Niacin is vitamin B3. It helps our bodies use energy from food and supports normal cell function. We get it from foods such as fish, poultry, peanuts, legumes, and enriched grains.
Most adults need roughly 14–16 milligrams of niacin equivalents daily, and most people in the United States get enough through food. The cholesterol-treatment doses studied in major trials were much larger: around 1,500–2,000 milligrams a day.
Meeting a nutritional need and taking a high dose to treat cholesterol are very different things. At those larger doses, niacin acts as a medication, even when purchased from a supplement shelf.
Why it once seemed so promising
Niacin’s appeal was understandable. It improved several measurements associated with cardiovascular risk, and earlier studies offered encouraging findings. Researchers also explored effects on blood vessels, inflammation, and how HDL functions.
Those were reasonable reasons to investigate it. However, early studies were conducted under different treatment conditions, and improving a biological process does not guarantee that a treatment’s overall benefits will outweigh its harms.
A laboratory report can tell us that a treatment changed something. It cannot, by itself, tell us that the person taking it is better protected.
What the larger studies taught us
Two major trials changed the conversation.
AIM-HIGH studied more than 3,400 people with cardiovascular disease who were receiving statin-based treatment. Adding high-dose niacin improved their lipid measurements, but it did not reduce cardiovascular events. The trial was stopped early because continuing was unlikely to demonstrate benefit.
HPS2-THRIVE studied more than 25,000 people. It also found no significant reduction in major vascular events when niacin was added to statin-based treatment. There were more serious adverse effects, including problems with blood sugar, bleeding, and infection.
One fair qualification: HPS2-THRIVE used niacin combined with laropiprant, a drug intended to reduce flushing. We cannot assign every adverse effect to niacin alone. But AIM-HIGH did not use laropiprant, and it also failed to show added cardiovascular benefit.
A broader Cochrane review likewise found no convincing reduction in deaths, heart attacks, or strokes.
The goal is a healthier person, and a better-looking lipid panel is only useful if it helps us get there.
What if your Lp(a) is elevated?
Lp(a)—pronounced “L-P little a”—is a largely inherited blood particle that can increase cardiovascular risk.
Niacin can lower it. That is true. What has not been demonstrated is that lowering it with niacin prevents cardiovascular events. The National Lipid Association recommends against using niacin to reduce cardiovascular risk through Lp(a) lowering.
Elevated Lp(a) deserves attention. The usual response is to address the risks we can effectively treat: LDL cholesterol, blood pressure, smoking, and diabetes management.
Depending on someone’s cardiovascular history and cholesterol levels, additional medications may be appropriate. A lower Lp(a) result alone is not proof that a supplement is protecting the heart.
When might niacin still be considered?
Niacin has legitimate uses, but they are more specific than routine heart-health supplementation.
Treating a deficiency: A diagnosed vitamin B3 deficiency, including pellagra, requires treatment. This is a nutritional problem with a different purpose and treatment plan.
Selected cases of severe triglyceride elevation: Prescription niacin retains an indication for severe hypertriglyceridemia in people at risk of pancreatitis. A clinician may occasionally consider it when other approaches are unsuitable or inadequate. This is a carefully monitored exception; the indication does not establish that niacin has been proven to prevent pancreatitis in outcome trials.
Routine use simply to raise HDL, lower Lp(a), or add another layer of protection to effective statin treatment is not supported by the current outcome evidence.
When the risks may outweigh the benefits
High-dose niacin can cause flushing, itching, stomach upset, liver injury, higher blood sugar, and increased uric acid, which can aggravate gout. Some sustained-release preparations carry particular liver risks. Different formulations should not be treated as interchangeable.
And “flush-free” does not mean “proven heart protection.” Niacinamide, another form of vitamin B3, does not have the same cholesterol effects as nicotinic acid.
If you take niacin, a useful question is: “What are we treating, what benefit do we expect, and does the latest evidence still support this choice?” Review the dose, formulation, and reason for taking it with your clinician before changing prescribed treatment.
There is strength in updating our thinking
Perhaps routine niacin for heart protection is best described as an older approach that deserves a fresh look.
That is not a criticism of everyone who once recommended it. Medical decisions are made with the information available, and that information changes.
There was a time when people lit cigarettes on airplanes as casually as we now reach for our headphones. Familiarity made it seem ordinary. Familiarity did not make it harmless. I am not equating niacin with smoking; I am thinking about how easily an accepted practice can become something we stop questioning.
We have also left many medical remedies behind as better evidence arrived. That is part of how medicine improves.
Changing our minds can be an act of care. We can respect what we once believed, appreciate the people who helped us, and still make a different decision today.
Research teaches us, if we allow it to.
And perhaps growing stronger and healthier begins with staying curious enough to listen.
With love and a willingness to keep learning,
🍯 Honey 🐝
This post is for general education. Individual treatment decisions should be made with your healthcare professional.
